Opium Analgesics FAQ


      From: mmanzo@mail.sas.upenn.edu (Marco Manzo)
      Newsgroups: alt.drugs
      Subject: FAQ list-Opioid Analgesics
      Date: 29 May 1994 19:16:02 GMT
      Message-ID: <2sapli$nca@netnews.upenn.edu>

      As suggested in the "Hydromorphone, Oxymorphone" thread, here is a sort of FAQ-list/summary of the opioid pain killers available in the United States.

       
      CATEGORY I. STRONG AGONISTS-- SEVERE PAIN
      GENERIC NAME TRADE NAME DOSAGE DURATION OF ACTION CONTROLLED SUBSTANCE
      CATEGORY
      HYDROMORPHONE DILAUDID 2-4 mg. every 4-6 hrs 4-5 hours Schedule II Narcotic
      avail in: 1,2,3,4,10 mg.tabs Parenteral (injection) 1,2,3,4 mg./mL ampules
      LEVORPHANOL LEVO-DROMORAN 2-3 mg. every 6-8 hrs. 4-5 hours Schedule II Narcotic
      dosages: 2 mg. tabs; injection: 2 mg./mL
      MEPERIDINE DEMEROL 50-150 mg. every 3-4 hrs 2-4 hours Schedule II Narcotic
      dosages: 50,100 mg. tabs; injection: 25,50,75,100 mg. vials
      METHADONE DOLOPHINE 40 mg. every 24 hrs 4-6 hours Schedule II Narcotic
      dosages: 5,10,40 mg. tabs; injection: 10 mg./mL 2.5-10 mg.injection every 3-4 hrs
      MORPHINE SULFATE 10-30 mg. every 4 hrs 4-5 hours Schedule II Narcotic
      dosages: 10,15,30 mg., tabs injection: 2,4,5,8,10,15 mg/mL, 30 mg. controlled release tablets 8-12 hrs.
      OXYMORPHONE NUMORPHON 5 mg. suppository every 4-6 hours 3-4 hours Schedule II Narcotic
      dosages: 5 mg. suppos., 1, 1.5 mg/mL injection, 1-1.5 mg. injection every 4-6 hours

       
      STRONG AGONISTS FOR INJECTION ONLY:
      GENERIC NAME TRADE NAME DOSAGE DURATION OF ACTION CONTROLLED SUBSTANCE
      CATEGORY
      FENTANYL SUBLIMAZE 0.05-0.1 mg. 1-1.5 hours Schedule II Narcotic
      dosages: 0.05 mL for injection repeat in 2 hours if needed
      SUFENTANIL SUFENTA 1-30 micrograms/kg. as needed for anesthesia Schedule II Narcotic
      dosages: 50 micrograms per mL in 1,2,5 mL ampules
      ALFENTANIL ALFENTA 0.5-3 micrograms/kg./minute Schedule II Narcotic
      dosage: 500 micrograms/mL ampules for injection IV infusion in balanced anesthesia

       
      CATEGORY II, MILD TO MODERATE AGONISTS, MODERATE TO SEVERE PAIN
      GENERIC NAME TRADE NAME DOSAGE DURATION OF ACTION CONTROLLED SUBSTANCE
      CATEGORY
      CODEINE SULFATE,PHOSPHATE 15-60 mg.
      every 4-6 hours
      3-4 hours Schedule II Narcotic
      dosage 15,30,60 mg. tablets 30,60 mg./mL for injection (when combined with acetaminophen or asprin it is a Schedule III Narcotic)
      OXYCODONE PERCODAN (with asprin) 5 mg. 3-4 hours Schedule II Narcotic
      dosage 5 mg. oxycodone per tablet PERCOCET (with tylenol) every 6 hours
      HYDROCODONE VICODIN,LORTAB 5-7 mg. 3-4 hours Schedule III Narcotic
      BITARTRATE LORCET,HYDROCET 5-7 mg. 4-6 hours
      dosages: either 2.5, 5, or 7 mg. hydrocodone with either asprin or tylenol

       
      CATEGORY III, WEAK AGONISTS, MILD TO MODERATE PAIN
      GENERIC NAME TRADE NAME DOSAGE DURATION OF ACTION CONTROLLED SUBSTANCE
      CATEGORY
      PROPOXYPHENE DARVON 50-100 mg.
      4 hrs
      4-5 hours Schedule IV
      Narcotic
      NAPSYLATE DARVOCET N-50
      DARVOCET N-100

       
      CATEGORY IV, MIXED AGONISTS/ANTAGONISTS, MODERATE TO SEVERE PAIN
      GENERIC NAME TRADE NAME DOSAGE DURATION OF
      ACTION
      CONTROLLED
      SUBSTANCE
      CATEGORY
      PENTAZOCINE TALWIN-NX 50-100 mg. 3 hours Schedule IV
      Narcotic
      dosage 50 mg. tablets 30 mg./mL
      in 1 and 2 mL ampules for injection
      every 3-4 hours 30 mg. injection (Pentazocine is mixed with Naxolone [an opiate antagonist]
      to prevent crushing of tabs. for iv injection)

       
      OTHER MIXED AGONIST-ANTAGONISTS:
      GENERIC NAME TRADE NAME DOSAGE DURATION OF
      ACTION
      CONTROLLED
      SUBSTANCE
      CATEGORY
      BUPRENORPHINE BUPRENEX 0.3 mg./ml ampules for injection Schedule V
      BUTORPHANOL STADOL 1-2 mg./ml for injection Not a controlled substance because of the strong antagonist efficacy
      NALBUPHINE NUBAIN 10-20 mg./ml for injection Not a controlled substance because of the strong antagonist efficacy

       


      HTML by: Slake.
      Made possible by: the MyReference Library Drug Archives